Ken Griffin Simulations Plus, Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$37.48 - $44.74 $71,212 - $85,006	1,900 Added 237.5%	2,700 $111,000
Q4 2023 Feb 14, 2024	SELL	$33.36 - $45.71 $120,096 - $164,556	-3,600 Reduced 81.82%	800 $35,000
Q3 2023 Nov 14, 2023	BUY	$40.03 - $51.51 $72,054 - $92,718	1,800 Added 69.23%	4,400 $183,000
Q2 2023 Aug 14, 2023	SELL	$40.45 - $48.0 $109,215 - $129,600	-2,700 Reduced 50.94%	2,600 $112,000
Q1 2023 May 15, 2023	BUY	$34.96 - $43.94 $153,824 - $193,336	4,400 Added 488.89%	5,300 $232,000

Q4 2022 Feb 14, 2023	SELL	$36.55 - $51.15 $248,539 - $347,820	-6,800 Reduced 88.31%	900 $32,000
Q3 2022 Nov 14, 2022	BUY	$47.75 - $66.88 $367,675 - $514,975	7,700 New	7,700 $374,000

173

15.8M

2.7K

11.7K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $803M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.